title

Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney Disease and Diabetes | AAFP

charset

UTF-8

description

Are sodium-glucose cotransporter-2 (SGLT-2) inhibitors effective in reducing complications for people with chronic kidney disease (CKD) and type 2 diabetes?

template

aafp-article-page

tags

aafp:publications/afp/departments/cochrane-for-clinicians,aafp:publications/afp/article-types/department,aafp:taxonomy/afp/diabetes,aafp:taxonomy/afp/kidney-disorders%2C-chronic,aafp:publications/afp/topics/kidney-disease/treatment,aafp:publications/afp/topics/diabetes--type-2/treatment,aafp:publications/filters/discipline/endocrinologic,aafp:publications/filters/discipline/nephrologic,aafp:publications/filters/content-focus/treatment,aafp:publications/filters/population/adults

og:title

Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney Disease and Diabetes

og:description

Are sodium-glucose cotransporter-2 (SGLT-2) inhibitors effective in reducing complications for people with chronic kidney disease (CKD) and type 2 diabetes?

og:image

https://www.aafp.org/dam/brand/aafp/pubs/afp/issues/2025/0500/cochrane.jpg

og:image:alt

AAFP logo in blue with orange flame in torch

og:url

https://www.aafp.org/pubs/afp/issues/2025/0500/cochrane-chronic-kidney-disease-diabetes.html

twitter:card

summary_large_image

twitter:site

@aafp

twitter:title

Sodium-Glucose Cotransporter-2 Inhibitors for People With Chronic Kidney Disease and Diabetes

twitter:description

Are sodium-glucose cotransporter-2 (SGLT-2) inhibitors effective in reducing complications for people with chronic kidney disease (CKD) and type 2 diabetes?

twitter:image

https://www.aafp.org/dam/brand/aafp/pubs/afp/issues/2025/0500/cochrane.jpg

canonical

https://www.aafp.org/pubs/afp/issues/2025/0500/cochrane-chronic-kidney-disease-diabetes.html

preconnect

https://ssl.aafp.org

preconnect

https://img.aafp.net

preconnect

https://css.aafp.net

preconnect

https://js.aafp.net